Evidence map›Paper›PMID 37194054›Full record

ArticleBMC biology2023

MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links.

Victoria Marini, Fedor Nikulenkov, Pounami Samadder, Sissel Juul, Birgitta R Knudsen, Lumir Krejci

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A perspective on tumor radiation resistance following high-LET radiation treatment.Journal of cancer research and clinical oncology · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Victoria MariniDepartment of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic.
Fedor NikulenkovDepartment of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic.
Pounami SamadderDepartment of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic.
Sissel JuulDepartment of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, 8000, Denmark.
Birgitta R KnudsenDepartment of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, 8000, Denmark.
Lumir KrejciDepartment of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic. lkrejci@chemi.muni.cz.ORCID 0000-0002-4732-1405
Masaryk University · CZAarhus University · DK

Funding

Wellcome Trust 206292/E/17/ZWellcome Trust 206292/Z/17/Z
6 · The paper itself

Abstract

backgroundDNA-protein cross-links (DPCs) are one of the most deleterious DNA lesions, originating from various sources, including enzymatic activity. For instance, topoisomerases, which play a fundamental role in DNA metabolic processes such as replication and transcription, can be trapped and remain covalently bound to DNA in the presence of poisons or nearby DNA damage. Given the complexity of individual DPCs, numerous repair pathways have been described. The protein tyrosyl-DNA phosphodiesterase 1 (Tdp1) has been demonstrated to be responsible for removing topoisomerase 1 (Top1). Nevertheless, studies in budding yeast have indicated that alternative pathways involving Mus81, a structure-specific DNA endonuclease, could also remove Top1 and other DPCs.

resultsThis study shows that MUS81 can efficiently cleave various DNA substrates modified by fluorescein, streptavidin or proteolytically processed topoisomerase. Furthermore, the inability of MUS81 to cleave substrates bearing native TOP1 suggests that TOP1 must be either dislodged or partially degraded prior to MUS81 cleavage. We demonstrated that MUS81 could cleave a model DPC in nuclear extracts and that depletion of TDP1 in MUS81-KO cells induces sensitivity to the TOP1 poison camptothecin (CPT) and affects cell proliferation. This sensitivity is only partially suppressed by TOP1 depletion, indicating that other DPCs might require the MUS81 activity for cell proliferation.

conclusionsOur data indicate that MUS81 and TDP1 play independent roles in the repair of CPT-induced lesions, thus representing new therapeutic targets for cancer cell sensitisation in combination with TOP1 inhibitors.

Indexed as

DNA-Binding ProteinsEndonucleasesPhosphoric Diester HydrolasesSaccharomyces cerevisiae ProteinsDNA DamageDNA RepairDNA Topoisomerases, Type ISaccharomyces cerevisiaeDNA-Binding ProteinsDNA Topoisomerases, Type IEndonucleasesMUS81 protein, S cerevisiaePhosphoric Diester HydrolasesSaccharomyces cerevisiae ProteinsTdp1 protein, S cerevisiaeTOP1 protein, S cerevisiaeDNA-protein cross-links repairMUS81TDP1Topoisomerase 1

Identifiers

PMID37194054
PMCPMC10189953
OpenAlexW4376871639

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.